Tromethamine

Tromethamine

SCHEMBL7403442

Cc1cc(COc2ccc(C(=O)NC3(CC(=O)NO)CCCN(Cc4ccccn4)C3)cc2)c2ccccc2n1.NC(CO)(CO)CO

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DHFRGARTPTGFRPTGIRPTGS1PTGS2TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8envmurAthyA

The experimentally established mechanism targets of Tromethamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 19/20 0.66
MMP13 P45452 1/20 0.62
ADAMTS4 O75173 2/20 0.60
MMP3 P08254 2/20 0.60
MMP7 P09237 2/20 0.60
ADAMTS1 Q9UHI8 2/20 0.60
ADAMTS5 Q9UNA0 2/20 0.60
MMP8 P22894 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tromethamine SCHEMBL7403751 0.96 ADAM17 (0.70) ADAM17MMP13
SCHEMBL6596591 0.95 ADAM17 (0.72) ADAM17MMP13ADAMTS4MMP3MMP7
Trifluoroacetic Acid SCHEMBL6598203 0.93 ADAM17 (0.67) ADAM17MMP13ADAMTS4MMP3MMP7
SCHEMBL6596212 0.91 ADAM17 (0.76) ADAM17MMP13ADAMTS4MMP3MMP7
Tromethamine SCHEMBL7492807 0.91 ADAM17 (0.70) ADAM17MMP13ADAMTS4MMP3MMP7
Tromethamine SCHEMBL7502726 0.90 ADAM17 (0.69) ADAM17MMP13ADAMTS4MMP3MMP7
Trifluoroacetic Acid SCHEMBL6598220 0.89 ADAM17 (0.71) ADAM17MMP13
SCHEMBL6596285 0.87 ADAM17 (0.83) ADAM17MMP13ADAMTS4MMP3MMP7
SCHEMBL6595533 0.87 ADAM17 (0.83) ADAM17MMP13ADAMTS4MMP3MMP7
SCHEMBL6597540 0.86 ADAM17 (0.77) ADAM17MMP13ADAMTS4MMP3MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263756-A2 BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA Bristol-Myers Squibb Pharma Company (US) 2002-12-11 EP disclosed
WO-2001070734-A2 BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-27 WO disclosed